Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Potential of emodepside for vector-borne disease control

View through CrossRef
Abstract Background Emodepside is an anthelmintic used in veterinary medicine that is currently under investigation in human clinical trials for the treatment of soil-transmitted helminths and possibly Onchocerca volvulus. Emodepside targets the calcium-activated voltage-gated potassium slowpoke 1 (SLO-1) channels of presynaptic nerves of pharynx and body wall muscle cells of nematodes leading to paralysis, reduced locomotion and egg laying, starvation, and death. Emodepside also has activity against Drosophila melanogaster SLO-1 channels. Orthologous SLO-1 genes are present in Anopheles gambiae and Aedes aegypti, suggesting that emodepside may have activity against mosquitoes. Methods Both Anopheles dirus and Ae. aegypti were blood-fed emodepside across a range of concentrations (1–10,000 nM) and mosquito survival was monitored for 10 days. Co-feeding experiments were also performed with An. dirus blood fed ivermectin at the concentrations that kills 25% (LC25) and 50% (LC50) of mosquitoes with and without emodepside at clinical peak concentration in humans (Cmax) and five times the Cmax, and mosquito survival was monitored for 10 days. Results Emodepside had weak mosquito-lethal effects in An. dirus but none observed in Ae. aegypti at the concentrations evaluated. The An. dirus emodepside LC50 was 4,623 [4,159–5,066] ng/ml which is > 100-fold greater than the peak concentrations seen in human. The ivermectin and emodepside co-feed experiment with An. dirus did not indicate any altered effect of ivermectin on mosquito survival when emodepside co-fed at human Cmax or five times that of the human Cmax. Conclusions Emodepside was not lethal to An. dirus at human-relevant concentrations and had no effect on Ae. aegypti survival. Thus, mass distribution of emodepside does not appear to be a potential tool for vector-borne disease control. Emodepside induced mortality in An. dirus does suggest that the SLO-1 channel could be a potential target for novel vector control and may warrant further investigation.
Title: Potential of emodepside for vector-borne disease control
Description:
Abstract Background Emodepside is an anthelmintic used in veterinary medicine that is currently under investigation in human clinical trials for the treatment of soil-transmitted helminths and possibly Onchocerca volvulus.
Emodepside targets the calcium-activated voltage-gated potassium slowpoke 1 (SLO-1) channels of presynaptic nerves of pharynx and body wall muscle cells of nematodes leading to paralysis, reduced locomotion and egg laying, starvation, and death.
Emodepside also has activity against Drosophila melanogaster SLO-1 channels.
Orthologous SLO-1 genes are present in Anopheles gambiae and Aedes aegypti, suggesting that emodepside may have activity against mosquitoes.
Methods Both Anopheles dirus and Ae.
aegypti were blood-fed emodepside across a range of concentrations (1–10,000 nM) and mosquito survival was monitored for 10 days.
Co-feeding experiments were also performed with An.
dirus blood fed ivermectin at the concentrations that kills 25% (LC25) and 50% (LC50) of mosquitoes with and without emodepside at clinical peak concentration in humans (Cmax) and five times the Cmax, and mosquito survival was monitored for 10 days.
Results Emodepside had weak mosquito-lethal effects in An.
dirus but none observed in Ae.
aegypti at the concentrations evaluated.
The An.
dirus emodepside LC50 was 4,623 [4,159–5,066] ng/ml which is > 100-fold greater than the peak concentrations seen in human.
The ivermectin and emodepside co-feed experiment with An.
dirus did not indicate any altered effect of ivermectin on mosquito survival when emodepside co-fed at human Cmax or five times that of the human Cmax.
Conclusions Emodepside was not lethal to An.
dirus at human-relevant concentrations and had no effect on Ae.
aegypti survival.
Thus, mass distribution of emodepside does not appear to be a potential tool for vector-borne disease control.
Emodepside induced mortality in An.
dirus does suggest that the SLO-1 channel could be a potential target for novel vector control and may warrant further investigation.

Related Results

Nonlinear optimal control for robotic exoskeletons with electropneumatic actuators
Nonlinear optimal control for robotic exoskeletons with electropneumatic actuators
Purpose To provide high torques needed to move a robot’s links, electric actuators are followed by a transmission system with a high transmission rate. For instance, gear ratios of...
Socio-Demographic and Eco-Epidemiological Parameters of Tick-Borne Infections Morbidity in Baikal Region
Socio-Demographic and Eco-Epidemiological Parameters of Tick-Borne Infections Morbidity in Baikal Region
The aim of the work was to compare the main socio-demographic and eco-epidemiological parameters of tick-borne viral encephalitis, tick-borne borrelioses and tick-borne rickettsios...
The need to implement one health approach in controlling vector-borne diseases in Nigeria
The need to implement one health approach in controlling vector-borne diseases in Nigeria
Introduction. The primary goal of this article is to raise attentiveness about the critical need for vector-borne disease control in Nigeria in relation to One Health, as well as t...
Population Biology of Vector-Borne Diseases
Population Biology of Vector-Borne Diseases
Abstract Population Biology of Vector-Borne Diseases is the first comprehensive survey of this rapidly developing field. The chapter topics provide an up-to-date pre...
Characterisation and zoonotic risk of tick viruses in public datasets
Characterisation and zoonotic risk of tick viruses in public datasets
AbstractTick-borne viruses remain a substantial zoonotic risk worldwide, so knowledge of the diversity of tick viruses has potential health consequences. Despite their importance, ...

Back to Top